Synergistic Prophylaxis on COVID-19 by Nature Golden Heart (Piper betle) & Swarna Bhasma
Himesh Soni, Sarvesh Sharma, Jitender K. Malik
Asian Journal of Research in Dermatological Science · pp. 60–66 · Published 1 Jul 2020
Abstract
Corona virus (COVID-19) is an enveloped RNA virus that is diversely initiated in humans and wildlife. An entirety of six species has been identified to cause disease in humans. Viral infections participate a vital role in human diseases and recent outbreaks is the influx globally in form of novel corona .The SS-RNA virus from the enveloped corona virus family caused SARS (Severe acute respiratory syndrome) which is life threatening viral infection. The spreading of infection is rapid in many countries of the world. As of March 26, 2020, there have been 462,684 confirmed cases globally, and 20,834 deaths have been registered. The World Health Organization (WHO) called COVID-19 a pandemic on March 11, 2020. In Ayurveda pandemics are called as Janapadodhvansa roga. Coronavirus is an example of the latter. Janapadodhvansa literally means “annihilation of society”. Swarna Bhasma is an proficient dosage form in the Ayurvedic treatment. In the conventional system of medicine some molecules of Gold are skillful for executive of various disorders. Various Sanskrit texts describe the medicinal uses of the heart shaped betel leaves. Leaves of Piper betel rich sources of numerous phytoceuticals and are used in traditional medicinal systems. Many investigation studies on Piper betle has reported its therapeutic properties like anti-malaria, antibacterial, antifungal, anti-diabetic, anti-platelet anti-allergic, oral hygiene and anti-asthmatic effect and wound healing. The present review based on previous outcome of various pharmacological activity of both herbal (Piper betle) and herbo-mineral (Swarna Bhasma) to illustrated the proposed mechanism of the combination of both may be used can be used as prophylaxis and therapeutic treatment for corona patient. Here we review the natural and traditional two drugs and the mechanisms whereby the virus infects cells. Based on this analysis we make conclusions about whether these drugs should be used while we wait for the results of clinical trials.
Cited by 0
No indexed citations yet.
Related research
- COVID 19 Disease Caused by Coronavirus 2 (SARS-CoV-2) (Severe Acute Respiratory Syndrome) — shares topic coverage
- Assessment of Anxiety in Healthcare Providers Working in ICU during COVID-19 Pandemics — shares topic coverage
- Azithromycin and Hydroxychloroquine Accelerate Recovery of Outpatients with Mild/Moderate COVID-19 — shares topic coverage
- Elevated Levels of Lactate Dehydrogenase Predicts Poor Outcomes for Patients with COVID-19: A Review — shares topic coverage
- Addressing the Challenges of Containing Covid-19 Spread in a Rural, Poor Area in India: A Case Study — shares topic coverage
Article metrics
Real usage data collected on this platform.
0
Page views
0
PDF downloads
0
Outbound clicks
0
Citations
Views by country
Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".
No views recorded yet.
Traffic sources
Referring site, by host.
No traffic recorded yet.
Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.